Grantham, Mayo, Van Otterloo & Co (GMO)’s Aecom ACM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
62,570
+29,010
+86% +$2.22M 0.01% 347
2026
Q1
$2.85M Buy
33,560
+17,357
+107% +$1.64M 0.01% 395
2025
Q4
$1.54M Buy
+16,203
New +$1.91M ﹤0.01% 429
2016
Q2
Sell
-400,000
Closed -$12.3M 564
2016
Q1
$12.3M Buy
400,000
+155,000
+63% +$4.3M 0.05% 217
2015
Q4
$7.36M Sell
245,000
-50,000
-17% -$1.5M 0.03% 219
2015
Q3
$8.12M Buy
+295,000
New +$8.57M 0.03% 209
2014
Q1
Sell
-13,378
Closed -$394K 559
2013
Q4
$394K Sell
13,378
-462
-3% -$14K ﹤0.01% 586
2013
Q3
$433K Buy
+13,840
New +$433K ﹤0.01% 572

Other funds holding ACM

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACM Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Aecom (ACM) stake by 86% in Q2 2026, buying an estimated $2.22M and bringing the position to 62,570 shares worth $4.37M. The position accounts for 0.01% of the portfolio, ranked #347.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACM in Q3 2013 and has held it in 8 quarters since. The position peaked at $12.3M in Q1 2016. 568 funds tracked by Wall St. Rank hold ACM as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 62,570 shares of Aecom worth $4.37M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 29,010 Aecom shares in Q2 2026, an estimated $2.22M.
  • Aecom made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #347 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Aecom in Q3 2013 and has held it in 8 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Aecom position peaked at $12.3M in Q1 2016.
  • 568 funds tracked by Wall St. Rank held Aecom as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.